Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prezatide copper acetate

Drug Profile

Prezatide copper acetate

Alternative Names: GHK-Cu; GraftCyte; Iamin; Iamin-1B; Iamin® gel; KPC 1193; Neova; PC 1020

Latest Information Update: 12 Nov 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ProCyte Corporation
  • Class Antihyperglycaemics
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Burns; Chronic wounds; Skin ulcer
  • Discontinued Diabetic foot ulcer; Inflammatory bowel diseases; Ulcerative colitis; Wounds

Most Recent Events

  • 12 Nov 2008 Typo fixed
  • 12 May 2005 ProCyte Corporation has been acquired by PhotoMedex
  • 18 Nov 2003 Discontinued - Phase-II for Inflammatory bowel disease in USA (Rectal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top